Post-approval studies (Phase 4)UnknownNCT02281266
What this trial is testing
Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection
Who this might be right for
Curable Hepatitis B Virus-Related Hepatocellular Carcinoma
Jia Fan 360